Drugs / DP-QB-PSA-005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07698002 | Jul 2026 → Aug 2027 expected | periprosthetic joint infection | Ottawa Hospital Research Institute | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DP-QB-PSA-005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07698002 ↗ |
| Modality | Other / unclassified | “each formed of a mixture of 5 bacteriophages” NCT07698002 ↗ |